科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 未找到姓氏以该字母开头的医生 A
  2. 未找到姓氏以该字母开头的医生 B
  3. 未找到姓氏以该字母开头的医生 C
  4. 查找姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 未找到姓氏以该字母开头的医生 F
  7. 未找到姓氏以该字母开头的医生 G
  8. 未找到姓氏以该字母开头的医生 H
  9. 未找到姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 未找到姓氏以该字母开头的医生 K
  12. 未找到姓氏以该字母开头的医生 L
  13. 查找姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 未找到姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 未找到姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

  1. David R. Deyle, M.D.

    David R. Deyle, M.D.

    1. Internist
    2. Medical Geneticist
    1. Rochester, MN
    擅长领域:

    Gene therapy, Osteogenesis imperfecta, Skeletal dysplasia

  2. John C. Morris, III, M.D.

    John C. Morris, III, M.D.

    1. Internist
    2. Endocrinologist
    1. Rochester, MN
    擅长领域:

    Gene therapy, Thyroid cancer, Hypothyroidism, Hyperthyroidism, Graves' disease

  3. Brittni A. Scruggs, M.D., Ph.D.

    Brittni A. Scruggs, M.D., Ph.D.

    1. Ophthalmologist
    1. Rochester, MN
    擅长领域:

    Photodynamic therapy, Gene therapy, Optical coherence tomography, Genetic counseling, Visual electrophysiology, Retinal... surgery, Laser eye surgery, Retinal exam, Anti-VEGF injection therapy, Lens replacement surgery, Retinal angiogram, Vitrectomy, Eye injection, Scleral buckling, Diabetic retinopathy, Retinal degeneration, Retinal detachment, Retinal disease, Stickler syndrome, Retinitis pigmentosa, Eye injury, Eye floaters, Macular degeneration, Retinal vein occlusion, Epiretinal membrane, Macular hole, Retinal artery occlusion, Pediatric trauma, Genetic eye disease, Eye infection, Vitreous detachment, Retinopathy of prematurity, Stargardt's disease, Macular edema, Vitreous hemorrhage, Inherited retinal disorders, Best vitelliform macular dystrophy

July 13, 2024
  1. MedLine Plus. Genes and gene therapy. https://medlineplus.gov/genesandgenetherapy.html. Accessed Jan. 31, 2024.
  2. How gene therapy can cure or treat diseases. U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/how-gene-therapy-can-cure-or-treat-diseases. Accessed Feb. 8, 2024.
  3. Gene therapy basics. American Society of Gene + Cell Therapy. https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-basics. Accessed Jan. 31, 2024.
  4. What are genetic therapies? National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/genetic-therapies. Accessed Jan. 31, 2024.
  5. What is gene therapy? U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy. Accessed Jan. 31, 2024.
  6. Flomenbergm P, et al. Overview of gene therapy, gene editing, and gene silencing. https://www.uptodate.com/contents/search. Accessed Jan. 31, 2024.
  7. Dara J, et al. Overview of gene therapy for inborn errors of immunity. https://www.uptodate.com/contents/search. Accessed Jan. 31, 2024.
  8. Kymriah (prescribing information). Novartis Pharmaceutical Corp.; 2022. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/kymriah-tisagenlecleucel. Accessed Jan. 31, 2024.
  9. Yescarta (prescribing information). Kite Pharma Inc.; 2023. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/yescarta-axicabtagene-ciloleucel. Accessed Jan. 31, 2024.
  10. Luxturna (prescribing information). Spark Therapeutics Inc.; 2022. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/luxturna. Accessed Jan. 31, 2024.
  11. Zolgensma (prescribing information). Novartis Gene Therapies Inc.; 2019. https://www.fda.gov/vaccines-blood-biologics/zolgensma. Accessed Jan. 31, 2024.
  12. Imlygic (prescribing information). Amgen Inc.; 2023. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/imlygic. Accessed Jan. 24, 2024.
  13. Shukla V, et al. The landscape of cellular and gene therapy products: Authorization, discontinuations and cost. Human Gene Therapy. Clinical Development. 2019; doi:10.1089/humc.2018.201.
  14. MedLine Plus. How does gene therapy work? https://medlineplus.gov/genesandgenetherapy.html. Accessed Jan. 31, 2024.
  15. Gene therapy — Frequently asked questions. National Organization for Rare Disorders Inc. https://rarediseases.org/gene-therapy/faqs. Accessed Jan. 31, 2024.
  16. Gene therapy — Frequently asked questions. Immune Deficiency Foundation. https://primaryimmune.org/understanding-primary-immunodeficiency/treatment/gene-therapy. Accessed Jan. 31, 2024.
  17. Deyle DR (expert opinion). Mayo Clinic. Feb. 8, 2024.
  18. Approved cellular and gene therapy products. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products. Accessed Feb. 12, 2024.

基因治疗